Hillary Clinton Would Make Taxpayers Fund Embryonic Stem Cell Research 
Email this article
Printer friendly page
by Steven Ertelt
LifeNews.com Editor
June 20, 2007
Washington, DC (LifeNews.com) — Should Hillary Clinton become president after next year’s elections, she promises to make taxpayers fund new embryonic stem cell research that requires the destruction of human life. Currently the only way to obtain embryonic stem cells is to kill days-old unborn children.
Clinton made the promise in remarks just before President Bush vetoed the latest Congressional bill overturning his policy preventing embryonic stem cell research funding.
‘So let me be very clear: When I am president, I will lift the ban on stem cell research," Clinton told a political conference in Washington this morning.
“This is just one example of how the President puts ideology before science, politics before the needs of our families, just one more example of how out of touch with reality he and his party have become," Clinton claimed.
"Yesterday, I met with a group of children suffering from juvenile diabetes. I co-chair the Alzheimer’s caucus in the Senate," Clinton added.
However, it appears the New York senator is the one who may be out of touch with the reality of stem cell research.
Though she claims otherwise, President Bush was the first to authorize federal funding of stem cell research, including on studies involving embryonic stem cells that had already been obtained.
From 2001 to 2004, the Bush Administration provided $54 million for human embryonic stem cell research pursued within clear moral bounds. During this same period of time, federal funding for non-embryonic stem cell research exceeded $1.7 billion.
Meanwhile, Clinton’s reference to Alzheimer’s includes the assumption that it will be cured by embryonic stem cell research and that Bush is somehow holding up progress on that.
Yet, because Alzheimer’s is not a disease involving one type of cell, one scientist says the use of embryonic stem cells is unlikely to have much effect.
"Alzheimer’s is a more global disease, with an effect on numerous kinds of cells," Steve Stice, a stem cell researcher at the University of Georgia, previously told the Atlanta Journal-Constitution newspaper. "That makes it much more difficult for a cell therapy to be effective."
